TP53 and astrocytoma (excluding glioblastoma): This observation suggests that immunostaining of astrocytomas for overall p53 protein production at diagnosis may be a valuable tool in the determination of clinical course and be helpful in better tailoring modalities of therapeutic intervention to the individual clinical case at hand.